1.
AIDS Patient Care STDS
; 17(9): 484, 2003 Sep.
Article
in English
| MEDLINE
| ID: mdl-14596253
2.
TreatmentUpdate
; 10(7): 6, 8, 1998 Sep.
Article
in English, French
| MEDLINE
| ID: mdl-11365783
ABSTRACT
AIDS: Due to the licensing of Nelfinavir in Canada, Agouron Pharmaceuticals will stop enrolling subjects into its Nelfinavir expanded access program. Current participants will continue receiving the drug under the program for up to 90 days following licensing or when private insurance coverage is granted. A toll-free number is provided for those needing help with finding payment options for Nelfinavir.^ieng
